1. Baseline differences in minor lymphocyte subpopulations may predict response to fingolimod in relapsing-remitting multiple sclerosis patients
Aina Teniente-Serra 1,2; José Vicente Hervás 3; Bibiana Quirant-Sánchez 1,2; María José Mansilla 1; Laia Grau-López 3; Cristina Ramo-Tello 3; Eva María Martínez-Cáceres 1,2
